BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 16597191)

  • 1. The effects of sustained-release-L-arginine formulation on blood pressure and vascular compliance in 29 healthy individuals.
    Miller AL
    Altern Med Rev; 2006 Mar; 11(1):23-9. PubMed ID: 16597191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
    J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis.
    McVeigh GE; Allen PB; Morgan DR; Hanratty CG; Silke B
    Clin Sci (Lond); 2001 Apr; 100(4):387-93. PubMed ID: 11256976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes.
    Martina V; Masha A; Gigliardi VR; Brocato L; Manzato E; Berchio A; Massarenti P; Settanni F; Della Casa L; Bergamini S; Iannone A
    Diabetes Care; 2008 May; 31(5):940-4. PubMed ID: 18268065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of losartan therapy on endothelial function in hypertensive patients.
    Sosa-Canache B; Hernández-Hernández R; Armas-Padilla MC; Armas-Hernández MJ; Cammarata-Segura R; Pacheco B; Guerrero J; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):166-71. PubMed ID: 17414585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endothelial function and arterial hypertension].
    Taddei S; Virdis A; Ghiadoni L; Salvetti A
    Ann Ital Med Int; 1995 Oct; 10 Suppl():85S-90S. PubMed ID: 8562274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals.
    Siasos G; Tousoulis D; Vlachopoulos C; Antoniades C; Stefanadi E; Ioakeimidis N; Andreou I; Zisimos K; Papavassiliou AG; Stefanadis C
    Int J Cardiol; 2008 Jun; 126(3):394-9. PubMed ID: 17588688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension.
    Wu G; Tian H; Han K; Xi Y; Yao Y; Ma A
    Clin Exp Hypertens; 2006 Jul; 28(5):489-97. PubMed ID: 16820345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular wall function as a risk marker for cardiovascular disease.
    Cohn JN
    J Hypertens Suppl; 1999 Dec; 17(5):S41-4. PubMed ID: 10706325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure profile and variability in hypertensives treated with L-arginine infusion.
    Czarnecka D; Malczewska-Malec M; Dembinska-Kiec A; Kawecka-Jaszcz K; Guevara I; Zdzienicka A
    Blood Press Monit; 1998 Apr; 3(2):91-96. PubMed ID: 10212336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of an L-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia.
    Abdelhamed AI; Reis SE; Sane DC; Brosnihan KB; Preli RB; Herrington DM
    Am Heart J; 2003 Mar; 145(3):E15. PubMed ID: 12660684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension in mice lacking the gene for endothelial nitric oxide synthase.
    Huang PL; Huang Z; Mashimo H; Bloch KD; Moskowitz MA; Bevan JA; Fishman MC
    Nature; 1995 Sep; 377(6546):239-42. PubMed ID: 7545787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: a randomized controlled trial.
    Hu J; Jiang X; Li N; Yu X; Perkovic V; Chen B; Zhao L; Neal B; Wu Y
    Hypertens Res; 2009 Apr; 32(4):282-8. PubMed ID: 19262499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects.
    Schlaich MP; Parnell MM; Ahlers BA; Finch S; Marshall T; Zhang WZ; Kaye DM
    Circulation; 2004 Dec; 110(24):3680-6. PubMed ID: 15569830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.